198 related articles for article (PubMed ID: 33194410)
1. Neurocognitive effects of six ketamine infusions and the association with antidepressant effects in treatment-resistant bipolar depression: a preliminary study.
Zheng W; Zhou YL; Wang CY; Lan XF; Zhang B; Yang MZ; Nie S; Ning YP
PeerJ; 2020; 8():e10208. PubMed ID: 33194410
[TBL] [Abstract][Full Text] [Related]
2. Neurocognitive performance and repeated-dose intravenous ketamine in major depressive disorder.
Zheng W; Zhou YL; Liu WJ; Wang CY; Zhan YN; Li HQ; Chen LJ; Li MD; Ning YP
J Affect Disord; 2019 Mar; 246():241-247. PubMed ID: 30590286
[TBL] [Abstract][Full Text] [Related]
3. Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression.
Shiroma PR; Albott CS; Johns B; Thuras P; Wels J; Lim KO
Int J Neuropsychopharmacol; 2014 Nov; 17(11):1805-13. PubMed ID: 24963561
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression.
Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Li M; Ning Y
J Psychopharmacol; 2018 Oct; 32(10):1118-1126. PubMed ID: 30260273
[TBL] [Abstract][Full Text] [Related]
5. A preliminary study of adjunctive ketamine for treatment-resistant bipolar depression.
Zheng W; Zhou YL; Liu WJ; Wang CY; Zhan YN; Lan XF; Zhang B; Ning YP
J Affect Disord; 2020 Oct; 275():38-43. PubMed ID: 32658821
[TBL] [Abstract][Full Text] [Related]
6. Repeated intravenous infusions of ketamine: Neurocognition in patients with anxious and nonanxious treatment-resistant depression.
Liu W; Zhou Y; Zheng W; Wang C; Zhan Y; Lan X; Zhang B; Li H; Chen L; Ning Y
J Affect Disord; 2019 Dec; 259():1-6. PubMed ID: 31430662
[TBL] [Abstract][Full Text] [Related]
7. The potential pro-cognitive effects with intravenous subanesthetic ketamine in adults with treatment-resistant major depressive or bipolar disorders and suicidality.
Zhou Y; Wang C; Lan X; Zheng W; Li H; Chao Z; Wu K; McIntyre RS; Ning Y
J Psychiatr Res; 2021 Dec; 144():312-319. PubMed ID: 34715598
[TBL] [Abstract][Full Text] [Related]
8. Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response.
Murrough JW; Wan LB; Iacoviello B; Collins KA; Solon C; Glicksberg B; Perez AM; Mathew SJ; Charney DS; Iosifescu DV; Burdick KE
Psychopharmacology (Berl); 2013 Sep; ():. PubMed ID: 24022236
[TBL] [Abstract][Full Text] [Related]
9. Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial.
Murrough JW; Burdick KE; Levitch CF; Perez AM; Brallier JW; Chang LC; Foulkes A; Charney DS; Mathew SJ; Iosifescu DV
Neuropsychopharmacology; 2015 Mar; 40(5):1084-90. PubMed ID: 25374095
[TBL] [Abstract][Full Text] [Related]
10. Neurocognitive performance of repeated versus single intravenous subanesthetic ketamine in treatment resistant depression.
Shiroma PR; Thuras P; Wels J; Albott CS; Erbes C; Tye S; Lim KO
J Affect Disord; 2020 Dec; 277():470-477. PubMed ID: 32871534
[TBL] [Abstract][Full Text] [Related]
11. Neurocognitive effects of subanesthetic serial ketamine infusions in treatment resistant depression.
Zavaliangos-Petropulu A; McClintock SM; Khalil J; Joshi SH; Taraku B; Al-Sharif NB; Espinoza RT; Narr KL
J Affect Disord; 2023 Jul; 333():161-171. PubMed ID: 37060953
[TBL] [Abstract][Full Text] [Related]
12. Neurocognitive effects of repeated ketamine infusions in comorbid posttraumatic stress disorder and major depressive disorder.
Albott CS; Lim KO; Erbes C; Thuras P; Wels J; Tye SJ; Shiroma PR
J Affect Disord; 2022 Jul; 308():289-297. PubMed ID: 35429529
[TBL] [Abstract][Full Text] [Related]
13. Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression.
Zheng W; Zhou YL; Liu WJ; Wang CY; Zhan YN; Li HQ; Chen LJ; Li MD; Ning YP
J Psychiatr Res; 2018 Nov; 106():61-68. PubMed ID: 30278319
[TBL] [Abstract][Full Text] [Related]
14. Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study.
Wilkowska A; Włodarczyk A; Gałuszko-Węgielnik M; Wiglusz MS; Cubała WJ
Neuropsychiatr Dis Treat; 2021; 17():2637-2646. PubMed ID: 34421299
[TBL] [Abstract][Full Text] [Related]
15. Baseline insomnia as a predictor of antidepressant efficacy to repeated intravenous ketamine for unipolar and bipolar depression: A preliminary study.
Liu W; Zhou Y; Wang C; Zheng W; Zhan Y; Lan X; Zhang B; Li H; Chen L; Li M; Ning Y
J Affect Disord; 2020 Jun; 271():1-8. PubMed ID: 32312692
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of repeated intravenous ketamine on subjective and objective psychosocial function in patients with treatment-resistant depression and suicidal ideation.
Zhou Y; Wang C; Lan X; Zheng W; Li H; Chao Z; McIntyre RS; Ning Y
J Affect Disord; 2022 May; 304():78-84. PubMed ID: 35176337
[TBL] [Abstract][Full Text] [Related]
17. Neurocognitive Effects of Ketamine and Esketamine for Treatment-Resistant Major Depressive Disorder: A Systematic Review.
Souza-Marques B; Santos-Lima C; Araújo-de-Freitas L; Vieira F; Jesus-Nunes AP; Quarantini LC; Sampaio AS
Harv Rev Psychiatry; 2021 Sep-Oct 01; 29(5):340-350. PubMed ID: 34366408
[TBL] [Abstract][Full Text] [Related]
18. Neurocognitive effects of repeated ketamine infusion treatments in patients with treatment resistant depression: a retrospective chart review.
Dai D; Miller C; Valdivia V; Boyle B; Bolton P; Li S; Seiner S; Meisner R
BMC Psychiatry; 2022 Feb; 22(1):140. PubMed ID: 35193541
[TBL] [Abstract][Full Text] [Related]
19. Cognitive Function Mediates the Anti-suicide Effect of Repeated Intravenous Ketamine in Adult Patients With Suicidal Ideation.
Zhou Y; Wang C; Lan X; Li W; Chao Z; Wu K; McIntyre RS; Ning Y
Front Psychiatry; 2022; 13():779326. PubMed ID: 35586411
[TBL] [Abstract][Full Text] [Related]
20. Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression.
Albott CS; Lim KO; Forbes MK; Erbes C; Tye SJ; Grabowski JG; Thuras P; Batres-Y-Carr TM; Wels J; Shiroma PR
J Clin Psychiatry; 2018; 79(3):. PubMed ID: 29727073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
